Effect of 900 MHz Electromagnetic Field Exposure During Different Trimesters of Pregnancy on TRPM2-Mediated Ferroptosis and Neurotoxicity in the Trigeminal Ganglion of Rats: Protective Role of Ferrostatin-1.

Developmental neurobiology · 2025 · Harm · Low evidence

← Research stream

HarmLow evidencePaper 5875

Study snapshot

PublicationDevelopmental neurobiology · 2025

Study typeanimal

Reported directionHarm

Evidence ratingLow

Abstract

Electromagnetic field (EMF) exposure, unavoidable in modern life, is linked to oxidative stress and ferroptosis, processes linked to neurodevelopmental disorders. This study investigated the effects of EMF exposure during different pregnancy trimesters on rat offspring trigeminal ganglia (TGs), focusing on transient receptor potential melastatin 2 (TRPM2) ion channels, and assessed the neuroprotective potential of ferrostatin-1 (Fer), a ferroptosis inhibitor, against EMF-induced damage. Pregnant rats were exposed to 900 MHz EMF for 2 h/day during early (1-7 days, EMF 1), mid (8-14 days, EMF 2), or late (15-21 days, EMF 3) gestation. Fer (2.5 µmol/kg, i.p.) was administered immediately after daily EMF exposure in Fer treatment groups. Offspring TG tissues were analyzed on postnatal Day 28 using histopathological, immunohistochemical, and biochemical approaches. EMF exposure significantly reduced antioxidant capacity and elevated lipid peroxidation, reactive oxygen species (ROS), pro-inflammatory cytokines, apoptotic markers, and TRPM2 activation, with the most pronounced alterations in mid-gestation exposure. Fer administration largely normalized these parameters and reduced structural damage in TG. In conclusion, these findings suggest that prenatal EMF triggers ferroptotic/apoptotic neurodegeneration via TRPM2, and that Fer holds promise as a neuroprotective agent.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typeanimal

Effect directionharm

PopulationPregnant rats and offspring (trigeminal ganglion assessed at postnatal day 28)

Sample sizeNot supplied

ExposureRF · 900 MHz · 2 h/day during gestation (early 1–7 days, mid 8–14 days, or late 15–21 days)

Evidence strengthLowConfidence: 78% · Peer reviewed: yes

Main findings

Prenatal 900 MHz EMF exposure (2 h/day) during gestation was associated with reduced antioxidant capacity and increased lipid peroxidation, ROS, pro-inflammatory cytokines, apoptotic markers, and TRPM2 activation in offspring trigeminal ganglion at postnatal day 28, with the most pronounced changes after mid-gestation exposure. Ferrostatin-1 administered after each daily exposure largely normalized measured parameters and reduced structural damage.

Outcomes measured

Antioxidant capacity
Lipid peroxidation
Reactive oxygen species (ROS)
Pro-inflammatory cytokines
Apoptotic markers
TRPM2 activation
Histopathological/structural damage in trigeminal ganglion
Ferroptosis-related changes (via ferrostatin-1 intervention)

Limitations

Sample size not reported in abstract
Specific exposure dosimetry (e.g., SAR, field strength) not reported in abstract
Animal model; relevance to humans not established in abstract
Outcomes assessed at a single postnatal time point (day 28)

View raw extracted JSON

{
  "study_type": "animal",
  "exposure": {
    "band": "RF",
    "source": null,
    "frequency_mhz": 900,
    "sar_wkg": null,
    "duration": "2 h/day during gestation (early 1–7 days, mid 8–14 days, or late 15–21 days)"
  },
  "population": "Pregnant rats and offspring (trigeminal ganglion assessed at postnatal day 28)",
  "sample_size": null,
  "outcomes": [
    "Antioxidant capacity",
    "Lipid peroxidation",
    "Reactive oxygen species (ROS)",
    "Pro-inflammatory cytokines",
    "Apoptotic markers",
    "TRPM2 activation",
    "Histopathological/structural damage in trigeminal ganglion",
    "Ferroptosis-related changes (via ferrostatin-1 intervention)"
  ],
  "main_findings": "Prenatal 900 MHz EMF exposure (2 h/day) during gestation was associated with reduced antioxidant capacity and increased lipid peroxidation, ROS, pro-inflammatory cytokines, apoptotic markers, and TRPM2 activation in offspring trigeminal ganglion at postnatal day 28, with the most pronounced changes after mid-gestation exposure. Ferrostatin-1 administered after each daily exposure largely normalized measured parameters and reduced structural damage.",
  "effect_direction": "harm",
  "limitations": [
    "Sample size not reported in abstract",
    "Specific exposure dosimetry (e.g., SAR, field strength) not reported in abstract",
    "Animal model; relevance to humans not established in abstract",
    "Outcomes assessed at a single postnatal time point (day 28)"
  ],
  "evidence_strength": "low",
  "confidence": 0.78,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "900 MHz",
    "RF-EMF",
    "pregnancy",
    "trimester timing",
    "rat",
    "trigeminal ganglion",
    "TRPM2",
    "ferroptosis",
    "ferrostatin-1",
    "oxidative stress",
    "neurotoxicity",
    "apoptosis",
    "inflammation"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.1002/dneu.23013
PubMed: 41146578

Read the original paper →

Related papers

← Back to the Research Library